Skip to content

Pneumonia, a lung infection

Precision in Severe Pneumonia Management (PRISM) - PRISM

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092812
Enrollment
100
Registered
2025-08-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J17- Pneumonia in diseases classified elsewhere

Interventions

Intervention1: The FilmArray Pneumonia Panel plus is a diagnostic kit: This kit utilizes multiplex PCR technology to rapidly identify multiple pathogens associated with pneumonia, including bacteria,

Sponsors

Dr Raja Dhar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults presenting with severe CAP (as defined by the CURB-65 score 2.BAL in the 1st 72 hrs of admission.

Exclusion criteria

Exclusion criteria: 1. On palliative care 2. Ventilated at another centre

Design outcomes

Primary

MeasureTime frame
Proportion of patients receiving appropriate antibiotic escalation/de-escalation at 24 hours post randomisationTimepoint: at 24 hours post randomization

Secondary

MeasureTime frame
1.Adults presenting with severe CAP (as defined by the CURB-65 score ) 2.Comparison of ancillary tests 3.Epidemiology of antibiotic resistance genes for bacteria causing co infections as well as primary pneumonia 4.Comparison of time to optimization of antibiotics ( biofire based ) as compared to positive cultures when available Timepoint: At discharge points

Countries

India

Contacts

Public ContactDr Amrita Bhattacharyya

The Calcutta Medical Research Institute

pupuldoc@gmail.com9919645454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026